International Biotechnology Trust (IBT) presentation at ShareSoc April 2018

The full video can be seen at:


IBT presentation at the ShareSoc growth company seminar in April 2018 by Lead Investment Manager Dr Carl Harald Janson.


International Biotechnology Trust offers investors access to the fast growing biotechnology sector through an actively managed, diversified fund. Its award winning fund managers at SV Health Investors are scientifically and medically trained with over 60 years of experience in this specialist sector between them. As well as investing in a wide ranging portfolio of global quoted biotechnology stocks, we include a small proportion of otherwise inaccessible carefully selected unquoted investments which have the potential to deliver additional returns over the long term. Excellent management teams, unique innovative products and strong potential for outperformance are the key criteria for inclusion in our diversified portfolio of assets.


Dr Carl Harald Janson, Lead Investment Manager introduction - 00:17

Performance 1, 3 & 5 years – 00:57

Dividend - 02:16

Share price/discount - 02:52

Dividend sustainability - 03:44

Biotech is a high growth sector - 04:35

Favourable regulatory environment - 07:55

Worldwide pharma sales - 08:25

M&A - 08:47

Risks - 10:25

The US market - 11:21

Sector valuation - 13:23

IBT investment process - 14:14

Risk mitigation - 15:04

Portfolio breakdown - 16:52

Oncology treatment options - 19:04

Top 10 holdings - 20:24

Unqouted portfolio - 21:10

Awards & Summary -23:08

Q&A -22:29

Share | Download(Loading)

Episodes Date

Load more

Podbean App

Play this podcast on Podbean App